PPARG and metabolic dysfunction-associated steatotic liver disease: To explore the effect of HJJPD on NAFLD, relevant signaling pathways (TNF-α, AKT1, PPARG, and PTGS2) predicted by network pharmacology were estimated by RT-qPCR (Figure 7).